Pivotal bioVenture Partners, based in California, backs life sciences startups from Pre-Seed to Series B, can lead rounds, and writes checks from $3 million to $30 million.
5 people on the investing team, 3 of them partners who can make the call. Partners are listed first.





Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Pivotal bioVenture Partners reports entry at pre-seed, seed, series a, series b.
Pivotal bioVenture Partners reports checks of $3M to $30M.
Yes. Pivotal bioVenture Partners says it can lead.
Peter Bisgaard (Managing Partner), Rob Hopfner (Managing Partner), Tony Ho (Senior Science Partner).
No recent activity since September 2026.
Work at Pivotal bioVenture Partners? Claim or correct this profile.